Public opinion on a mandatory COVID-19 vaccination policy in France: a cross-sectional survey

Clin Microbiol Infect. 2022 Mar;28(3):433-439. doi: 10.1016/j.cmi.2021.10.016. Epub 2021 Nov 10.

Abstract

Objectives: Reaching the last pockets of unvaccinated people is challenging, and has led to the consideration of mandatory vaccination for coronavirus disease 2019 (COVID-19). Our aim was to assess attitudes toward mandatory COVID-19 vaccination in France before the announcement of-and factors associated with opposition to-this type of policy.

Methods: Between the 10th and 23rd May 2021, we conducted a cross-sectional online survey among a representative sample of the French population aged 18 and over, and a specific sample of the French senior population aged over 65.

Results: Among 3056 respondents, 1314 (43.0%) were in favour of mandatory COVID-19 vaccination, 1281 (41.9%) were opposed to such a policy, and 461 (15.1%) were undecided. Among opponents to mandatory COVID-19 vaccination for the general population, 385 (30.05%) were in favour of mandatory COVID-19 vaccination for healthcare workers (HCWs). In multivariate analysis, the age groups 18-24 and 25-34 years were significantly more opposed than the reference group (>75 years old) with respective adjusted odds ratio (aOR) and 95% confidence interval (95%CI) 4.67 (1.73-12.61) and 3.74 (1.57-8.93). Having no intention of getting COVID-19 vaccination was strongly associated with opposition to mandatory vaccination (aOR 10.67, 95%CI 6.41-17.76). In comparison with partisans of the centre, partisans of the far left and green parties were more likely to be opposed to mandatory COVID-19 vaccine, with respective aORs (95%CI) of 1.89 (1.06-3.38) and 2.08 (1.14-3.81).

Conclusion: Attitudes toward mandatory COVID-19 vaccination are split in the French general population, and the debate might become politicized.

Keywords: Attitudes; COVID-19; Mandatory vaccine; Partisanship; Politics; Vaccination; Vaccine.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • COVID-19 Vaccines*
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Cross-Sectional Studies
  • France / epidemiology
  • Humans
  • Policy
  • Public Opinion
  • SARS-CoV-2
  • Vaccination

Substances

  • COVID-19 Vaccines